Welcome and Introductions hosted by Arlene Padron.
Plenary Session: “Advancing Model-Informed Drug Development (MIDD): A Holistic & Integrative Approach” presented by Rajanikanth Madabushi, U.S. Food and Drug Administration.
Session Moderators: John DiBella/Arlene Padron
Presented at SLP MIDD+ Virtual Conference February 16th-17th, 2022
Disclaimer: This presentation reflects the views and thoughts of the author and should not be considered to represent the Food and Drug Administrations policies.